Post-marketing approval medical

Post-market approval medical affairs This involves the promotion of each product by marketing and sales functions and the oversight of this process by pharmaceutical physicians. Two other critical post-marketing components are as... 

Post-market approval medical affairs—this involves the promotion of each product bymarketing and sales functions and the oversight of this process by pharmaceutical physicians. Two other critical postmarketing components are first, continued learning about the safety and efficacy of the product in normal medical practice, as opposed to clinical trials and second, the development of new or improved uses of the product as more is learned about it and as medical science moves on. The former of these two functions is termed pharmacovigilance and the latter product evergreening . 

Combination medications, including opioid plus NSAID preparations, are more effective than either drug alone for relief of acute pain, including post-surgical pain (1 ]. Vicoprofen", hydrocodone plus ibuprofen, was developed in 1997. Combunox , oxycodone plus ibuprofen, was developed in 2001 and approved for use in 2004 [2]. Reprexain also was marketed in 2004, while Ibudone was released in 2006. These combination medications were approved for use for approximately 7-10 days for relief of acute moderate... 

---